From a daraxonrasib to blood tests that may spot tumours years before symptoms appear, researchers say oncology is entering a new era of precision treatment.
@broadinstitute.org @edinburghup.bsky.social
Roche Greywolf Therapeutics @mitpress.bsky.social
theprint.in/feature/canc...
theprint.in
The new cancer care revolution. Early detection, targeted drugs, hope beyond chemo
From a pancreatic cancer drug that doubles survival to blood tests that may spot tumours years before symptoms appear, researchers say oncology is entering a new era of precision treatment.